TransMolecular was acquired by Morphotek on April 4, 2011
life science Company

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 166 acquisitions of life science companies in 2011, including 20 acquisitions by private equity firms, and 146 by strategics.

TransMolecular, Inc.

840 Memorial Drive, Second Floor,
Cambridge, Massachusetts 02139
United States,
(617)995-3050
www.transmolecular.com

TransMolecular is a neuroscience therapeutics company discovering and developing novel, proprietary drugs to diagnose and treat cancer and pain.

Life Science M&A - Last 3 Years

TransMolecular was acquired by Morphotek on April 4, 2011.

Join Mergr to view this profile - and discover more life science acquisitions of companies like TransMolecular.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.6K Private Equity Firms
  • 129K M&A Transactions
  • 138K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 36K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.